These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11469223)

  • 1. Quantitation of HCV RNA in liver of patients with chronic hepatitis C.
    Martinelli A; Brown D; Morris A; Dhillon A; Dayley P; Dusheiko G
    Arq Gastroenterol; 2000; 37(4):203-7. PubMed ID: 11469223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
    Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease.
    Anand BS; Velez M
    World J Gastroenterol; 2004 Aug; 10(16):2409-11. PubMed ID: 15285030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
    Reedy DW; Loo AT; Levine RA
    Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.
    McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW
    Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.
    Lirussi F; Beccarello A; Bortolato L; Morselli-Labate AM; Crovatto M; Ceselli S; Santini G; Crepaldi G
    Liver; 1999 Oct; 19(5):381-8. PubMed ID: 10533795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
    Mizokami M; Orito E; Gibo Y; Suzuki K; Ohba K; Ohno T; Lau JY
    Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management.
    Gupta RK; Sakhuja P; Majumdar K; Ali S; Srivastava S; Sachdeva S; Sharma BC; Puri AS
    Indian J Pathol Microbiol; 2018; 61(3):345-349. PubMed ID: 30004052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment.
    Gervais A; Martinot M; Boyer N; Auperin A; Le Breton W; Degott C; Valla D; Marcellin P
    J Hepatol; 2001 Sep; 35(3):399-405. PubMed ID: 11592602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C.
    Kondo M; Tanaka K; Ikeda M; Arata S; Saito S; Sakaguchi T; Morimoto M; Fujii T; Mitsui K; Okazaki H; Hoshino M; Sekihara H
    J Gastroenterol Hepatol; 1996 Mar; 11(3):236-40. PubMed ID: 8742919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases.
    Montalto G; Zignego AL; Ruggeri MI; Giannini C; Soresi M; Monti M; Carroccio A; Careccia G; Di Martino D; Giannelli F
    Dig Dis Sci; 1997 Aug; 42(8):1703-7. PubMed ID: 9286237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
    Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
    Maylin S; Laouénan C; Martinot-Peignoux M; Panhard X; Lapalus M; Nicolas-Chanoine MH; Bedossa P; Asselah T; Marcellin P
    J Clin Virol; 2012 Jan; 53(1):43-7. PubMed ID: 22099210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
    Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
    Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
    Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of hepatitis C virus RNA in liver tissue as a predictive marker of the response to interferon therapy in chronic hepatitis C.
    Hasui T; Shimomura H; Tsuji H; Wato M; Tsuji T
    Acta Med Okayama; 1994 Jun; 48(3):151-7. PubMed ID: 7524269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.